Effect of nucleosid analog and peginterferon alfa 2a sequential therapy on patients with chronic hepatitis B
Not Applicable
Recruiting
- Conditions
- Chronic hepatitis B
- Registration Number
- JPRN-UMIN000013811
- Lead Sponsor
- General Internal Medicine2 Kawasaki Medical School
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients receiving Chinese herb (sho-sai-ko-to) 2) Patients with history of interstitial pneumonia 3) Patients with auto immune hepatitis 4) Patients with hypersensitivity to interferon 5) Patients with hypersensitivity to biological agents 6) Patients with neutropenia (<1500/mm3), thrombocytopenia (<90000/mm3), or anemia (Hb<12g/dL) 7) Cirrhotic patients 8) Patients with history of HCC 9) Doctors consider inadequate
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method drug free ALT<40 HBV-DNA<5.0Log/ml
- Secondary Outcome Measures
Name Time Method